Brief: Immix Biopharma Announces Pricing Of $150 Million Underwritten Offering Of Common Stock
21/05/2026 11:33
May 21 (Reuters) - Immix Biopharma Inc IMMX.O: IMMIX BIOPHARMA ANNOUNCES PRICING OF $150 MILLION UNDERWRITTEN OFFERING OF COMMON STOCK IMMIX BIOPHARMA INC: PRICING OF OFFERING OF 16.8 MILLION SHARES AT PRICE TO PUBLIC OF $8.94 PER SHARE Source text: ID:nGNE8FDzPh Further company coverage: IMMX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immix Biopharma
See all newsBrief: Immix Biopharma Announces Closing Of $125 Million Underwritten Offering Of Common Stock
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Brief: Immix Biopharma Announces Pricing Of $125 Million Underwritten Offering Of Common Stock
Brief: Immix Biopharma Announces 89% Complete Response Rate At Interim Update Across All Nexicart-2 Patients, With Mrd-Negativity Indicating Potential To Reach Up To 98% Complete Response Rate
Immix Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary